Wong Richard
Laboratory of Cell Biology, Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10021, USA.
Bioessays. 2006 May;28(5):460-4. doi: 10.1002/bies.20402.
Oligodendrocytes are known to express (Ca2+)-permeable glutamate receptors and to have low resistance to oxidative stress, two factors that make them potentially susceptible to injury. Oligodendrocyte injury is intrinsic to the loss of function experienced in conditions ranging from cerebral palsy to spinal cord injury, focal ischaemia and multiple sclerosis. NMDA receptors, a subtype of glutamate receptors, are vital to the remodeling of synaptic connections during postnatal development and associative learning abilities in adults and possibly in improvements in oligodendrocyte function. Previous studies had failed to detect NMDA receptor mRNA or current in oligodendrocytes but three new papers demonstrate NMDA receptor expression in oligodendrocytes and discuss its implications for ischaemia therapy.
已知少突胶质细胞表达(钙离子)通透型谷氨酸受体,并且对氧化应激的耐受性较低,这两个因素使得它们可能易于受到损伤。少突胶质细胞损伤是从脑瘫到脊髓损伤、局灶性缺血和多发性硬化等多种病症中功能丧失的内在原因。NMDA受体是谷氨酸受体的一种亚型,对于出生后发育期间突触连接的重塑以及成年人的联想学习能力至关重要,并且可能对少突胶质细胞功能的改善也很重要。先前的研究未能在少突胶质细胞中检测到NMDA受体mRNA或电流,但三篇新论文证明了少突胶质细胞中存在NMDA受体表达,并讨论了其对缺血治疗的意义。